Paradigm Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Paradigm Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,300	Closed	-$78.4K	–	552
2017 Q2	$78.4K	Sell	5,300 -5,500	-51%	-$91.7K	0.02%	459
2017 Q1	$172K	Sell	10,800 -12,200	-53%	-$176K	0.03%	402
2016 Q4	$290K	Sell	23,000 -700	-3%	-$13K	0.06%	238
2016 Q3	$664K	Sell	23,700 -4,100	-15%	-$138K	0.12%	192
2016 Q2	$973K	Buy	27,800 +7,400	+36%	+$233K	0.17%	106
2016 Q1	$559K	Hold	20,400	–	–	0.1%	204
2015 Q4	$698K	Sell	20,400 -33,300	-62%	-$1.04M	0.12%	170
2015 Q3	$1.54M	Buy	53,700 +39,700	+284%	+$1.7M	0.2%	148
2015 Q2	$627K	Hold	14,000	–	–	0.07%	273
2015 Q1	$484K	Buy	+14,000	New	+$381K	0.05%	332

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Paradigm Asset Management's DPLO Position: Q3 2017 in Review

Paradigm Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2017, closing a stake of 5,300 shares — an estimated $78.4K sold.

Paradigm Asset Management first reported a position in DPLO in Q1 2015 and held it in 10 quarters. The position peaked at $1.54M in Q3 2015. 165 funds tracked by Wall St. Rank hold DPLO as of Q3 2017.

Paradigm Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2017 after selling out during the quarter.
Paradigm Asset Management sold 5,300 DIPLOMAT PHARMACY, INC. shares in Q3 2017, an estimated $78.4K.
Paradigm Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 10 quarters.
Paradigm Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $1.54M in Q3 2015.
165 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2017.

Based on Paradigm Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.